Evaluation of Combined Biomarkers for Tumor Response to Immunotherapy (I/O) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Ramdani, H. [1 ]
Falk, M. [2 ]
Schatz, S. [2 ]
Tiemann, M. [2 ]
Heukamp, L. [2 ]
Schuuring, E. [3 ]
Groen, H. [3 ]
Griesinger, F. [4 ]
机构：
[1] Carl Von Ossietzky Univ Oldenburg, Innere Med Onkol, Oldenburg, Germany
[2] Hamatopathol Hamburg, Hamburg, Germany
[3] Univ Med Ctr Groningen, Groningen, Netherlands
[4] Carl von Ossietzky Univ Oldenburg, Pius Hosp, Dept Hematol & Oncol, Med Campus, Oldenburg, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; Immune Checkpoint Inhibitors; tumor mutational burden;
D O I：
10.1016/j.jtho.2019.08.1568
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-63
引用
收藏
页码：S732 / S733
页数：2
相关论文
共 50 条
  • [21] The Influence of Circulating Tumor DNA Analysis on Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
    Grinberg, R.
    Roisman, L.
    Geva, S.
    Lefterova, M.
    Quinn, K.
    Gutman, L. Soussan
    Dvir, A.
    Yair, R.
    Twito, T.
    Lanman, R.
    Peled, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S925 - S926
  • [22] Predicting response to immunotherapy in advanced non-small cell lung cancer
    Rebordao Pires, M.
    Amorim Costa, C.
    Cunha Pereira, T.
    Monteiro, J. C.
    Domingues, I.
    Caetano, A. C.
    Meira Garcia, A. R.
    Jesus, E.
    Sousa, G.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S768 - S768
  • [23] The Evaluation of Serum Biomarkers for Non-small Cell Lung Cancer (NSCLC) Diagnosis
    Fang, Rui
    Zhu, Yong
    Khadka, Vedbar S.
    Zhang, Fan
    Jiang, Bin
    Deng, Youping
    FRONTIERS IN PHYSIOLOGY, 2018, 9
  • [24] Analysis of correlations between driver mutations and biomarkers with response to immunotherapy in patients with metastatic non-small cell lung cancer (NSCLC).
    Yio, Jiang
    Wolf, Brian
    Yang, Amber
    Bayewitz, Ashrei Y.
    Xu, Yiqing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
    Moya-Horno, Irene
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [26] Treatment Patterns in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in the Era of Immunotherapy (IO)
    Stenehjem, D.
    Lubinga, S.
    Betts, K. A.
    Tang, W.
    Jenkins, M.
    Yuan, Y.
    Hartman, J.
    Rao, S.
    Lam, J.
    Waterhouse, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S17 - S17
  • [27] Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
    Dugage, Matthieu Roulleaux
    Albarran-Artahona, Victor
    Laguna, Juan Carlos
    Chaput, Nathalie
    Vignot, Stephane
    Besse, Benjamin
    Mezquita, Laura
    Auclin, Edouard
    EUROPEAN JOURNAL OF CANCER, 2023, 184 : 179 - 196
  • [28] Combined immunotherapy for non-small cell lung cancer
    Shiraishi, Yoshimasa
    ANNALS OF ONCOLOGY, 2022, 33 : S416 - S416
  • [29] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [30] Dietary pattern and the corresponding gut microbiome in response to immunotherapy in Thai patients with advanced non-small cell lung cancer (NSCLC)
    Sitthideatphaiboon, Piyada
    Somlaw, Nicha
    Zungsontiporn, Nicha
    Ouwongprayoon, Pongsakorn
    Sukswai, Narittee
    Korphaisarn, Krittiya
    Poungvarin, Naravat
    Aporntewan, Chatchawit
    Vinayanuwattikun, Chanida
    Hirankarn, Nattiya
    Chanida, Vinayanuwattikun
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345